The hepatitis B vaccine is one of the most potent immunizations, usually providing decades of protection against the deadly liver virus. But in about 10% of people it doesn’t work, and in 2020, Amy Huei-Yi Lee, a systems biologist at Simon Fraser University, and her colleagues set out to determine whether they could predict who would benefit. The scientists found that data on recipients’ immune systems such as the abundance of certain proteins and the activity patterns of a few genes foretold whether they would generate defenses against the virus. “We got a sense of what factors drive the vaccine response and what [doesn’t],” Lee says.
Trending
- Abia govt approves new climate change policy, prioritises disability inclusion
- World Hijab Day: Group seek review of NYSC uniforms
- Libya deports undocumented Nigerian migrants
- My husband asks for sex 8 times every night, woman tells court
- Anambra seeks LG chairmen’s support for measles–rubella vaccination campaign
- Librarians’ Council lauds Northwest varsity for establishing well-equipped library, e-library
- LAWMA arrests cart pushers for illegal dumping on Lagos–Badagry expressway
- Kaduna eliminates Trachoma as public health threat
